BioXcel Therapeutics
BTAI
£1.49
Share price
-5.42%
Change (1 day)
-95.84%
Change (1 year)
Categories
Revenue for BioXcel Therapeutics (BTAI)
Revenue in 2024 (TTM): £1.78 Million
According to BioXcel Therapeutics's latest financial reports the company's current revenue (TTM 
) is £1.76 Million. In 2023 the company made a revenue of £1.08 Million an increase over the revenue in the year 2022 that were of £0.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioXcel Therapeutics from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | £1.78 M | 65.12% |
| 2023 | £1.08 M | 249.46% |
| 2022 | £0.3 M | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |